Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents
Clinical trial NCT02212457 · COMPLETED
Trial details
- NCT number
- NCT02212457
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-21
- Primary completion
- 2015-05-22
- Enrollment
- 1063
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.